Cure HHT will fund breakthrough research, supporting the best global science to uncover the mechanisms underlying the disease, improve treatment, and ultimately find a cure for Hereditary Hemorrhagic Telangiectasia (also known as Osler-Weber-Rendu Syndrome). The grant recipients listed below were selected with the invaluable assistance of the Cure HHT Scientific Review Committee, comprised of the Cure HHT Scientific Research Director, Chairman of the Cure HHT Global Research and Medical Advisory Board and scientific peer reviewers who generously volunteer their time to Cure HHT.
Use the filters below to explore research grants and awards by year and topic:
